DO NOT BUY TABEX BEFORE READING THIS
CHECK YOUR TABEX SOURCE BEFORE YOU ORDER
Know which Tabex is being offered before you pay
Before ordering Tabex, establish exactly which product is being offered and who will supply it. Products bearing the name are presented in different packaging, and the questions about their origin and reliability deserve your attention. This warning explains why we recommend the Bulgarian product supplied in blue boxes.
The version we recommend on our website
On our Official Tabex website, we offer the original Tabex manufactured by Sopharma Bulgaria. Its blue packaging is the version to look for when you want the authentic Bulgarian product. Choosing a familiar product from an identifiable supplier helps reduce the uncertainty of ordering online.
Licensed versions have also been offered in green packaging. Quality concerns surrounding that version are the reason for the withdrawal information later on this page. We urge you to take those concerns seriously when deciding what you are prepared to buy.
Establish who is behind the offer
Look for a clear company identity and usable contact information before placing an order. A website should tell you who is taking your payment and where the product comes from. If the business or product origin cannot be identified, you cannot properly verify the offer.
Avoid unknown sellers and suspiciously cheap offers. Check the seller’s reputation, then compare the written product details with the packaging shown. Confirm that both describe the version you intend to receive. Resolve an unclear description before paying, so you can establish what the seller is promising to supply.
Read the withdrawal information before ordering
Our concern is the reliability of what you receive when you buy Tabex to help you stop smoking. The notices below explain the quality problem reported by the Polish authority and the subsequent withdrawals. They provide the basis for the recommendation made on this page.
The quality concerns behind Tabex withdrawals
Poland’s Chief Pharmaceutical Inspectorate ordered selected batches of Tabex, Cytisinum 1.5 mg coated tablets, to be withdrawn from the market because they failed, or were suspected of failing, to meet the required impurity standards. The action applied across Poland and was intended to protect product quality and public health.
The impurity that prompted the concern
N-formylcytisine was the impurity identified in the quality concerns behind the decisions. Testing of an initial batch produced a result outside the required specification. That finding led to its withdrawal and raised the need to examine whether further supplies were affected.
Why additional batches were withdrawn
The initial action was followed by the withdrawal of additional batches after further concerns about compliance with the same impurity requirements. These subsequent measures were precautionary and took immediate effect. They show why the quality history of the product being offered deserves attention before you order.
The issue was the product’s compliance with quality requirements. The withdrawal decisions required the affected supplies to be removed from the marketplace. This is the regulatory action behind our warning about the reliability of the version offered in green packaging.
Reporting and the official record
TVN24 Biznes also reported on the recall and the failure to satisfy impurity quality guidelines. The regulatory record is available through the official Polish withdrawal register, in Polish. It provides the authority’s notices and the product details to which they refer.
Order through our Official Tabex website
To buy the product we recommend, place your order through our Official Tabex website. Keep your order confirmation, invoice and seller details after purchasing. Together, these provide the information needed to trace the transaction and check the product that was ordered if you need to verify it later.
